Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Multiple Biomarker Approach to Risk Stratification in COVID-19

Circulation(2021)10.1161/circulationaha.120.053311Source: DataRank Database

Multiple Biomarker Approach to Risk Stratification in COVID-19 is a research paper published in Circulation (2021). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.09)OA: greenTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Vuthy Nguy,Yindalon Aphinyanaphongs ORCID,Jonathan Newman ORCID,Yuhe Xia ORCID,Harmony R. Reynolds ORCID

Live enrichment

PubMed:33587646 PMC:PMC7996053 OpenAlex:https://openalex.org/W3131261074

NHLBI NIH HHS

Grant: K23 HL125991

NHLBI NIH HHS

Grant: K23 HL150315

NHLBI NIH HHS

Grant: R35 HL144993

NHLBI NIH HHS

Grant: R01 HL139909

FWCI

4.09

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

green

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7996053

publisherhttps://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.120.053311

journalhttps://doi.org/10.1161/circulationaha.120.053311

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33587646

Fields of Study

Cardiovascular Function and Risk FactorsCOVID-19 Clinical Research StudiesCardiovascular Disease and AdiposityBiomarkersC-Reactive ProteinCOVID-19ComorbidityFibrin Fibrinogen Degradation ProductsHospital MortalityHospitalizationHumansOdds RatioRetrospective StudiesRisk AssessmentSARS-CoV-2Troponin I

MeSH Terms

COVID-19SARS-CoV-2C-Reactive ProteinFibrin Fibrinogen Degradation ProductsHospitalizationHumansRetrospective StudiesBiomarkersComorbidityOdds RatioHospital MortalityRisk AssessmentTroponin I

Keywords

MedicinePopulationCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseInfectious disease (medical specialty)TroponinInflammationBiomarkersC-reactive ProteinFibrin Fragment DCovid-19

Sustainable Development Goals

SDG 0: Good health and well-being